sur Biotest AG (ETR:BIO)
Biotest AG Under Review for Legal Structure Change
Biotest AG has received a formal request from its majority shareholder, Grifols S.A., to convene an extraordinary general meeting. The agenda includes a proposal to transform Biotest AG from a stock corporation into a partnership limited by shares, known as Biotest GmbH & Co. KGaA.
If approved, a new entity, Biotest Management GmbH, will join as the general partner with unlimited liability. The firm's name will change accordingly, but shareholder rights and shares will remain unchanged. The Management Board is tasked with evaluating the compliance of this request with the German Stock Corporation Act before any meeting is convened and determining whether to support the proposal or suggest alternatives.
This move signifies a potentially pivotal shift in the company's legal and operational structure.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Biotest AG